Publication

A randomized open-label comparison of the impact of aripiprazole versus risperidone on sexual functioning (RAS study)

de Boer, M. K., Wiersma, D., Bous, J., Sytema, S., van der Moolen, A. E. G. M., Wilffert, B., Hamamura, T. & Knegtering, H., Aug-2011, In : Journal of Clinical Psychopharmacology. 31, 4, p. 523-525 3 p.

Research output: Contribution to journalLetterAcademicpeer-review

APA

de Boer, M. K., Wiersma, D., Bous, J., Sytema, S., van der Moolen, A. E. G. M., Wilffert, B., ... Knegtering, H. (2011). A randomized open-label comparison of the impact of aripiprazole versus risperidone on sexual functioning (RAS study). Journal of Clinical Psychopharmacology, 31(4), 523-525. https://doi.org/10.1097/JCP.0b013e318222bb29

Author

de Boer, Marrit K ; Wiersma, Durk ; Bous, Johan ; Sytema, Sjoerd ; van der Moolen, Andrea E G M ; Wilffert, Bob ; Hamamura, Takashi ; Knegtering, Henderikus. / A randomized open-label comparison of the impact of aripiprazole versus risperidone on sexual functioning (RAS study). In: Journal of Clinical Psychopharmacology. 2011 ; Vol. 31, No. 4. pp. 523-525.

Harvard

de Boer, MK, Wiersma, D, Bous, J, Sytema, S, van der Moolen, AEGM, Wilffert, B, Hamamura, T & Knegtering, H 2011, 'A randomized open-label comparison of the impact of aripiprazole versus risperidone on sexual functioning (RAS study)', Journal of Clinical Psychopharmacology, vol. 31, no. 4, pp. 523-525. https://doi.org/10.1097/JCP.0b013e318222bb29

Standard

A randomized open-label comparison of the impact of aripiprazole versus risperidone on sexual functioning (RAS study). / de Boer, Marrit K; Wiersma, Durk; Bous, Johan; Sytema, Sjoerd; van der Moolen, Andrea E G M; Wilffert, Bob; Hamamura, Takashi; Knegtering, Henderikus.

In: Journal of Clinical Psychopharmacology, Vol. 31, No. 4, 08.2011, p. 523-525.

Research output: Contribution to journalLetterAcademicpeer-review

Vancouver

de Boer MK, Wiersma D, Bous J, Sytema S, van der Moolen AEGM, Wilffert B et al. A randomized open-label comparison of the impact of aripiprazole versus risperidone on sexual functioning (RAS study). Journal of Clinical Psychopharmacology. 2011 Aug;31(4):523-525. https://doi.org/10.1097/JCP.0b013e318222bb29


BibTeX

@article{4eb7bd8436e045e493611258dc89adbe,
title = "A randomized open-label comparison of the impact of aripiprazole versus risperidone on sexual functioning (RAS study)",
keywords = "INDUCED HYPERPROLACTINEMIA, ANTIPSYCHOTICS, SCHIZOPHRENIA, OLANZAPINE, DISORDERS, PROLACTIN, TRIAL",
author = "{de Boer}, {Marrit K} and Durk Wiersma and Johan Bous and Sjoerd Sytema and {van der Moolen}, {Andrea E G M} and Bob Wilffert and Takashi Hamamura and Henderikus Knegtering",
year = "2011",
month = "8",
doi = "10.1097/JCP.0b013e318222bb29",
language = "English",
volume = "31",
pages = "523--525",
journal = "Journal of Clinical Psychopharmacology",
issn = "0271-0749",
publisher = "LIPPINCOTT WILLIAMS & WILKINS",
number = "4",

}

RIS

TY - JOUR

T1 - A randomized open-label comparison of the impact of aripiprazole versus risperidone on sexual functioning (RAS study)

AU - de Boer, Marrit K

AU - Wiersma, Durk

AU - Bous, Johan

AU - Sytema, Sjoerd

AU - van der Moolen, Andrea E G M

AU - Wilffert, Bob

AU - Hamamura, Takashi

AU - Knegtering, Henderikus

PY - 2011/8

Y1 - 2011/8

KW - INDUCED HYPERPROLACTINEMIA

KW - ANTIPSYCHOTICS

KW - SCHIZOPHRENIA

KW - OLANZAPINE

KW - DISORDERS

KW - PROLACTIN

KW - TRIAL

U2 - 10.1097/JCP.0b013e318222bb29

DO - 10.1097/JCP.0b013e318222bb29

M3 - Letter

VL - 31

SP - 523

EP - 525

JO - Journal of Clinical Psychopharmacology

JF - Journal of Clinical Psychopharmacology

SN - 0271-0749

IS - 4

ER -

ID: 5357367